Vietnam

Current Distributors Profile

Our network has distributors have product portfolios that include basic lab equipment from worldwide known name brands; reagents and consumables for molecular biology, food testing and Bio Education; and state of the art molecular detection devices.

Along with a strong sales staffs, they have application and technical support teams.  They promote products using traditional direct sales and exhibitions, digital marketing campaigns and use of seminars.  They also create local language sales tools.

b2b connect has a relationship with distributors in Vietnam that we can contact to see which one may be a good fit with your product portfolio.

 Market

Across the country, new biotechnology research centres to tackle cancer, diabetes, and antibiotic-resistant infections are being planned or already up and running. Some of these are well-stocked with the latest equipment.

For example, the Institute of Biotechnology and the Military Medical University in Hanoi are well equipped with microarrays, high-resolution electron microscopes and mass spectrometers. These centres are working on proteomic and genomic research to develop treatments for unmet diseases such as diabetes, high blood pressure and cancer.

Some of these research powerhouses are already making significant progress in therapeutic applications of biotechnology. For example, NanoGen Inc. in Ho Chi Minh City will soon provide both Vietnam and international markets with relatively cheap cancer treatments by producing biosimilar monoclonal antibodies that can specifically target cancer cells.

Others focus on tailoring biotechnology to diseases prevalent in Vietnam. For example, Vabiotech Company in Hanoi uses a reverse genetics approach to synthesise vaccines for Japanese encephalitis and hepatitis B, which affects many Vietnamese people and increases the risk of liver cancer.

In Nha Trang, the Institute of Vaccine Research is producing safe vaccines for the country's most common diseases, including tuberculosis, tetanus and diphtheria, among others.

And while Vietnam is progressing in applied biotechnology, it is not ignoring basic research. Ngoc K. Phan at the University of Ho Chi Minh City, for example, has done pioneering work in establishing embryonic and adult stem cell lines for planned clinical studies.

Organisations such as the Asia-Pacific International Molecular Biology Network and UCSF Global Health Sciences have made a significant impact by providing assistance in networking, training and sponsorship for their collaborators in Vietnam.

And multibillion dollar investments in science parks, such as the Saigon Hi-Tech Park in Ho Chi Minh City, by industry giants including Intel and Nidec have promoted scientific entrepreneurship across Vietnam. These developments are providing opportunities to invest in Vietnam's biotechnology potential. 

The national government is also stepping up its support to biotechnology. Inspired by breakthroughs in gene therapy in China, it has, for example, established the Vietnam Gene Therapy Center within a major public hospital in Hanoi.

But there are still challenges ahead. In particular, the country's biotechnology researchers need stronger infrastructure, more institutional and external funding, opportunities for international collaboration, and better access to peer-review journals and networking opportunities.

Vietnam has already achieved the critical mass required to establish multi-disciplinary biotechnology research and development that meets international standards.

Perhaps most importantly, we have intrinsic qualities and resources to develop biotechnology as a major force for modernising the country. Our strong tradition of medical practice and knowledge-based talents assure that we are capable of acquiring advanced biotechnologies to meet future challenges.

Vietnamese researchers have ample opportunities to make home-grown discoveries and applications of great value not only to Vietnam, but also for the global scientific community.